EUVIMEDEUVIMED entdecken
Crossref

TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression

Khaoula Elghazali, Mouad Najih, Zineb Sakhi, Youssef Ennaji, Abdelilah Laaraqui, Rida Tagajdid, Abdessamad Amine, Moulay Mustapha Ennaji

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-11442-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Khaoula Elghazali und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biotechnology, Agri-Food, Materials and Environment, Departement of Biology, Faculty of Science and Techniques-Mohammedia, University H…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Serine Endopeptidases. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: TMPRSS2, a transmembrane serine protease and common partner in oncogenic TMPRSS2-ERG fusions, is regulated by androgen receptors and is implicated in prostate tumorigenesis. The nonsynonymous SNP rs12329760 (C > T; Val160Met) has been hypothesized to alter TMPRSS2 proteolytic activity, potentially enhancing AR signaling and contributing to aggressive tumor behavior. However, data on this variant in North African populations remain sparse. METHODS: A case-control study was conducted including 50 Moroccan men diagnosed with prostate cancer (PCa) and 50 matched controls. Genotyping of rs12329760 was performed using TaqMan allelic discrimination assays. Genotype and allele distributions were analyzed and correlated with clinicopathological factors, including serum PSA levels, Gleason score, family history, smoking status, and other demographic or clinical variables. RESULTS: The CT (44% vs. 26%, P = 0.016) and TT (20% vs. 8%, P = 0.031) genotypes, as well as the T allele (43% vs. 21%, P = 0.002), were significantly more frequent in PCa patients than controls and were associated with increased disease risk. Carriers of the CT + TT genotypes exhibited significantly higher PSA levels (≥ 10 ng/mL, P = 0.004), Gleason scores (≥ 7, P = 0.018).Significant associations were also observed with positive family history (P < 0.001) and smoking (P < 0.001). No associations were found with age at diagnosis, T-stage. CONCLUSIONS: The TMPRSS2 rs12329760 T allele is associated with elevated prostate cancer risk and more severe clinicopathological features in Moroccan men. These findings highlight the potential prognostic relevance of the V160M variant and emphasize the need for further cellular and molecular studies to elucidate its functional role in AR signaling, TMPRSS2-ERG fusion biology, and ERG-related tumor aggressiveness. Such insights may contribute to the development of risk-stratified PCa management and tailored active surveillance strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsSerine EndopeptidasesHumansMalePolymorphism, Single NucleotideCase-Control StudiesPrognosisMiddle AgedBiomarkers, TumorAgedDisease ProgressionGenotypeMoroccoGenetic Predisposition to DiseaseProstate-Specific AntigenAllelesReceptors, AndrogenGene FrequencyOncogene Proteins, Fusion

Stichwörter der Autor:innen

Androgen receptor signalingGenetic susceptibilityMolecular biomarkerProstate cancerRs12329760 (V160M)TMPRSS2TMPRSS2–ERG fusionTranslational research

Substanzen

Serine EndopeptidasesTMPRSS2 protein, humanBiomarkers, TumorProstate-Specific AntigenReceptors, AndrogenOncogene Proteins, Fusion

Autor:innen und Institutionen

  • Laboratory of Biotechnology, Agri-Food, Materials and Environment, Departement of Biology, Faculty of Science and Techniques-Mohammedia, University Hassan II of Casablanca,, Casablanca, 20360, Morocco.
  • Center of Virology, Infectious and Tropical Diseases, Mohammed V Military Teaching Hospital, Rabat, Morocco.
  • Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, Morocco.
  • Sequencing Unit, Laboratory of Virology, Royal School of Military Health Service, Rabat, Morocco.
  • Laboratory of Biotechnology, Agri-Food, Materials and Environment, Departement of Biology, Faculty of Science and Techniques-Mohammedia, University Hassan II of Casablanca,, Casablanca, 20360, Morocco. m.ennaji@yahoo.fr.
  • Laboratory of Biotechnology, Agri-Food, Materials and Environment, Departement of Biology, Faculty of Sciences and Techniques, Mohammedia, Hassan II University of Casablanca (20650), Mohammedia, PO Box 146, Morocco. m.e…

Zitieren

APA

Elghazali, K., Najih, M., Sakhi, Z., Ennaji, Y., Laaraqui, A., Tagajdid, R., Amine, A., & Ennaji, M. M. (2026). TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-11442-5

Vancouver

Elghazali K, Najih M, Sakhi Z, Ennaji Y, Laaraqui A, Tagajdid R, et al. TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-11442-5

BibTeX
@article{Elghazali2026,
  author = {Elghazali, Khaoula and Najih, Mouad and Sakhi, Zineb and Ennaji, Youssef and Laaraqui, Abdelilah and Tagajdid, Rida and Amine, Abdessamad and Ennaji, Moulay Mustapha},
  title = {TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-11442-5}
}
Kostenlos starten →